Fresolimumab is a human monoclonal antibody made by cloning a unique white blood cell, with all subsequent antibodies derived from it tracing back to the unique parent cell; it has a target of TGF Beta one, two and three.
Fresolimumab is a human monoclonal antibody made by cloning a unique white blood cell, with all subsequent antibodies derived from it tracing back to the unique parent cell; it has a target of TGF Beta one, two and three.